We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

219 hedge funds and large institutions have $743M invested in ARK Genomic Revolution ETF in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 55

0.32% less ownership

Funds ownership: 72.38% → 72.06% (-0.32%)

8% less funds holding

Funds holding: 239 → 219 (-20)

13% less capital invested

Capital invested by funds: $854M → $743M (-$111M)

26% less call options, than puts

Call options by funds: $79.9M | Put options by funds: $108M

32% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 41

Holders
219
Holders Change
-20
Holders Change %
-8.37%
% of All Funds
2.68%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.02%
New
28
Increased
60
Reduced
55
Closed
41
Calls
$79.9M
Puts
$108M
Net Calls
-$28.1M
Net Calls Change
+$211M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$61M
2
Goldman Sachs
Goldman Sachs
New York
+$25M
3
Morgan Stanley
Morgan Stanley
New York
+$24.3M
4
JFG
Jefferies Financial Group
New York
+$22M
5
HI
Humankind Investments
New York
+$11.3M

Top Sellers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$59.2M
2
Citigroup
Citigroup
New York
-$27.3M
3
Jane Street
Jane Street
New York
-$14.2M
4
Bank of America
Bank of America
North Carolina
-$14.1M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$11.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCC
76
Compass Capital Corp
Massachusetts
$389K +$378K +12,920 New
RIL
77
Rothschild Investment LLC
Illinois
$382K – – –
AAP
78
Arax Advisory Partners
Colorado
$377K +$11.4K +389 +3%
OC
79
Oppenheimer & Co
New York
$364K +$39.4K +1,345 +11%
KFAS
80
Keating Financial Advisory Services
Kansas
$359K -$69.2K -2,364 -15%
GWP
81
Gateway Wealth Partners
Wisconsin
$349K +$387K +13,222 New
MWA
82
Medallion Wealth Advisors
Connecticut
$348K -$674 -23 -0.2%
NCM
83
Next Capital Management
New York
$345K – – –
SC
84
Sierra Capital
Florida
$334K – – –
SB
85
SIG Brokerage
New York
$334K -$901K -30,770 -71%
GWM
86
Geneos Wealth Management
Colorado
$331K – – –
AA
87
Acorns Advisers
California
$322K +$44.7K +1,528 +14%
PCM
88
Ping Capital Management
New York
$317K +$351K +12,000 New
CAG
89
Csenge Advisory Group
Florida
$304K +$337K +11,502 New
SPC
90
Sigma Planning Corp
Michigan
$287K +$1.23K +42 +0.4%
VW
91
Vance Wealth
California
$281K – – –
DAS
92
Dynamic Advisor Solutions
Arizona
$279K +$2.52K +86 +0.8%
QIM
93
Quantitative Investment Management
Virginia
$273K +$303K +10,352 New
JIP
94
Jaffetilchin Investment Partners
Florida
$262K -$101K -3,433 -26%
MC
95
Moors & Cabot
Massachusetts
$255K +$282K +9,640 New
CA
96
Cambridge Advisors
Nebraska
$246K +$30.2K +1,031 +12%
SIAS
97
Summit Investment Advisory Services
Minnesota
$245K +$14.5K +495 +6%
NFG
98
Northbridge Financial Group
Florida
$236K +$7.58K +259 +3%
DWP
99
Daymark Wealth Partners
Ohio
$233K +$2.93K +100 +1%
Credit Agricole
100
Credit Agricole
France
$229K +$254K +8,664 New
2 3
4
5 6

ARKG Hedge Fund Activity: Q1 2026 in Review

219 of the 8,172 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2026, worth a combined $743M — down 13% from $854M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of ARKG and 28 opened new positions — a net loss of 13 holders — while 55 trimmed existing stakes and 60 added.

The largest buyer was JP Morgan Chase, adding an estimated $61M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $59.2M.

  • 219 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2026, down from 239 in Q4 2025.
  • Funds reported $743M of ARK Genomic Revolution ETF stock for Q1 2026, down 13% quarter-over-quarter.
  • 28 funds opened new ARK Genomic Revolution ETF positions in Q1 2026 and 41 closed out, a net change of -13 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q1 2026 was JP Morgan Chase, an estimated $61M added.
  • The largest ARK Genomic Revolution ETF seller in Q1 2026 was BNP Paribas Financial Markets, an estimated $59.2M sold.

Based on aggregated 13F filings for Q1 2026.